Next Article in Journal
Preparation and Antitumor Activity of CS5931, A Novel Polypeptide from Sea Squirt Ciona Savignyi
Previous Article in Journal
Looking Beyond the Terrestrial: The Potential of Seaweed Derived Bioactives to Treat Non-Communicable Diseases
Article Menu

Export Article

Open AccessFeature PaperReview
Mar. Drugs 2016, 14(3), 62;

Integrated (Meta) Genomic and Synthetic Biology Approaches to Develop New Biocatalysts

BIOMERIT Research Centre, School of Microbiology, University College Cork, National University of Ireland, Cork, Ireland
School of Microbiology, University College Cork, Cork, Ireland
School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Perth WA 6845, Australia
Author to whom correspondence should be addressed.
Academic Editor: Paul Long
Received: 18 February 2016 / Revised: 18 February 2016 / Accepted: 11 March 2016 / Published: 21 March 2016
View Full-Text   |   Download PDF [1671 KB, uploaded 21 March 2016]   |  


In recent years, the marine environment has been the subject of increasing attention from biotechnological and pharmaceutical industries as a valuable and promising source of novel bioactive compounds. Marine biodiscovery programmes have begun to reveal the extent of novel compounds encoded within the enormous bacterial richness and diversity of the marine ecosystem. A combination of unique physicochemical properties and spatial niche-specific substrates, in wide-ranging and extreme habitats, underscores the potential of the marine environment to deliver on functionally novel biocatalytic activities. With the growing need for green alternatives to industrial processes, and the unique transformations which nature is capable of performing, marine biocatalysts have the potential to markedly improve current industrial pipelines. Furthermore, biocatalysts are known to possess chiral selectivity and specificity, a key focus of pharmaceutical drug design. In this review, we discuss how the explosion in genomics based sequence analysis, allied with parallel developments in synthetic and molecular biology, have the potential to fast-track the discovery and subsequent improvement of a new generation of marine biocatalysts. View Full-Text
Keywords: synthetic biology; metagenomics; biocatalysis; marine; biodiscovery; chassis; vector; heterologous expression synthetic biology; metagenomics; biocatalysis; marine; biodiscovery; chassis; vector; heterologous expression

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Parages, M.L.; Gutiérrez-Barranquero, J.A.; Reen, F.J.; Dobson, A.D.; O’Gara, F. Integrated (Meta) Genomic and Synthetic Biology Approaches to Develop New Biocatalysts. Mar. Drugs 2016, 14, 62.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top